Workflow
Summit Midstream Partners, LP(SMC)
icon
Search documents
Summit Midstream Corporation Announces Pricing of Offering of $250 Million of Additional 8.625% Senior Secured Second Lien Notes Due 2029
Prnewswire· 2025-01-07 22:29
HOUSTON, Jan. 7, 2025 /PRNewswire/ -- Summit Midstream Corporation (NYSE: SMC) ("SMC" or the "Company") announced today that Summit Midstream Holdings, LLC (the "Issuer"), which is a subsidiary of the Company, has priced the previously announced offering (the "Offering") of $250.0 million in aggregate principal amount of additional 8.625% Senior Secured Second Lien Notes due 2029 (the "Additional Notes") at 103.375% of par, plus accrued and unpaid interest from July 26, 2024 to, but excluding, the issue dat ...
Summit Midstream Corporation Announces Proposed Offering of $250 Million of Additional 8.625% Senior Secured Second Lien Notes Due 2029
Prnewswire· 2025-01-07 14:22
HOUSTON, Jan. 7, 2025 /PRNewswire/ -- Summit Midstream Corporation (NYSE: SMC) ("SMC" or the "Company") announced today that Summit Midstream Holdings, LLC (the "Issuer"), which is a subsidiary of the Company, has commenced an offering (the "Offering") of $250.0 million in aggregate principal amount of additional 8.625% Senior Secured Second Lien Notes due 2029 (the "Additional Notes"). The Additional Notes will be issued under the same indenture as the Issuer's $575.0 million in aggregate principal amount ...
Phio Pharmaceuticals Announces Positive Safety Monitoring Committee (SMC) Recommendation to Continue to Third Dose Cohort in its Clinical Study of PH-762
Newsfile· 2024-12-19 12:45
Phio Pharmaceuticals Announces Positive Safety Monitoring Committee (SMC) Recommendation to Continue to Third Dose Cohort in its Clinical Study of PH-762Phio's Lead Compound PH-762 demonstrates encouraging safety profile in 2nd cohort with recommendation to escalate to next dose concentrationDecember 19, 2024 7:45 AM EST | Source: Phio Pharmaceuticals Corp.Marlborough, Massachusetts--(Newsfile Corp. - December 19, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnol ...
Summit Midstream Partners, LP(SMC) - 2024 Q3 - Quarterly Report
2024-11-12 21:06
Table of Contents or UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-42201 Summit Midstream Corporation (Exact name of registrant as specified in its charter) Delaware (State ...
Summit Midstream Partners, LP(SMC) - 2024 Q3 - Earnings Call Transcript
2024-11-12 18:12
Summit Midstream Corporation (NYSE:SMC) Q3 2024 Earnings Conference Call November 12, 2024 10:00 AM ET Company Participants Randall Burton – Director of Finance and Investor Relations Heath Deneke – President, Chief Executive Officer and Chairman Bill Mault – Chief Financial Officer Conference Call Participants Operator Hello, and welcome to Summit Midstream Corporation Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, th ...
Summit Midstream Partners, LP(SMC) - 2024 Q3 - Quarterly Results
2024-11-12 13:18
EXHIBIT 99.1 Summit Midstream Corporation 910 Louisiana Street, Suite 4200 Houston, TX 77002 Summit Midstream Corporation Reports Third Quarter 2024 Financial and Operating Results Houston, Texas (November 12, 2024) – Summit Midstream Corporation (NYSE: SMC) ("Summit", "SMC" or the "Company") announced today its financial and operating results for the three months ended September 30, 2024. Highlights • Third quarter 2024 net loss of $197.5 million, including $142.6 million non-cash income tax expense to pri ...